Press Releases | Adaptive Biotechnologies

Skip to main navigation

Overview(current)

Stock
Stock Quote & Chart
Analyst Coverage

Governance
Leadership
Board of Directors
Committee Composition
Governance Documents

SEC Filings(current)

News & Events
Press Releases
Events
Presentations

Resources
Frequently Asked Questions
Email Alerts
Investor Contact

Press Releases

Looking for media resources?
Please visit our media resource center.

Year

Adaptive Biotechnologies Announces a Collaboration with Amgen to Advance Clinical Development of the clonoSEQ Assay in Multiple Myeloma

11-06-2017 at 5:00 PM EST
Adaptive Biotechnologies Expands Leadership to Bolster Integration of Immune Profiling into Clinical Care Setting

07-27-2017 at 5:00 PM EDT
Adaptive Biotechnologies Announces a Collaboration with Janssen Biotech, Inc. to use the clonoSEQ® Assay to Measure Minimal Residual Disease in Ongoing and Future DARZALEX® Multiple Myeloma Trials

06-21-2017 at 5:00 PM EDT
Adaptive Biotechnologies and Collaborators to Present Six Studies Leveraging Immunosequencing in Lymphoid, Non-Small Cell Lung, and Colorectal Cancers at the 2017 American Society of Clinical Oncology Annual Meeting

05-30-2017 at 5:00 PM EDT
Adaptive Biotechnologies Publishes Ground-Breaking Proof-of-Principle Experiment in Nature Genetics

04-03-2017 at 5:00 PM EDT
Adaptive Biotechnologies Announces a Collaboration with Amgen to Advance Development of clonoSEQ Assay in Acute Lymphoblastic Leukemia

01-06-2017 at 5:00 PM EST

Displaying 161 - 166 of 166

Pagination

First page
Previous page
…
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Current page 17

Print Page
RSS Feeds
Contacts

email

Keep up to date with Adaptive

Sign up to receive our press releases via email

© Adaptive Biotechnologies. All Rights Reserved. Legal & Privacy

Privacy Policy | Cookie Policy | Notice at Collection | Do Not Sell or Share My Info (CA Residents) | Terms of Service | Code of Conduct

© Adaptive Biotechnologies. All Rights Reserved. Legal & Privacy